Cancer Leagues call for overhaul of EU drug pricing transparency rules
In a new report, ‘Behind the Price Tag’, the Association of European Cancer Leagues (ECL) has renewed calls for a major overhaul of the EU’s pharmaceutical pricing rules, arguing that the EU’s long-standing Transparency Directive no longer reflects the realities of today’s










